Activating p38gamma, a naturally protective enzyme in the brain, may help to prevent the development of Alzheimer's disease symptoms. Researchers showed the naturally protective effects of p38gamma could be harnessed to improve memory in the later stages of Alzheimer's disease.
Increased kynurenic acid production has been implicated in the pathology of schizophrenia. The findings provide a new target for cell-specific treatments that help reduce the production of kynurenic acid and reduce symptoms of schizophrenia.
Researchers have identified a psychological pathway that can lead to body dysmorphia, causing an increased risk of both eating and exercise disorders.